The CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel-Influenza A/H7 Assay has received an emergency use authorization from the FDA. The test, which will run on the Applied Biosystems 7500 Fast Dx Real-Time PCR platform, is intended to identify the presence of influenza A virus subtype H7N9 in patients exhibiting symptoms of respiratory infection.

Related Summaries